We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,228

National Advertising Division confirms: Make sure your testimonials have evidentiary support
  • Porter Wright Morris & Arthur LLP
  • USA
  • November 29 2016

Many health and fitness companies know that federal and state laws prohibit unfair or deceptive practices, including false advertising. But many


OPDP issues fifth untitled letter of the year to Supernus for misrepresenting Oxtellar XR in KOL video
  • Loeb & Loeb LLP
  • USA
  • November 29 2016

In its fifth untitled letter in 2016, the OPDP raised concerns about a Spanish KOL video suggesting Supernus' treatment for partial seizures can be


FTC Addresses Homeopathic Drug Advertising
  • Klein Moynihan Turco LLP
  • USA
  • November 23 2016

The Federal Trade Commission (“FTC”) recently released an enforcement policy statement regarding marketing claims for products in the over-the-counter


Court Issues $29 Million Judgment Against Pure Green Coffee Weight-Loss Pills in FTC Deceptive Advertising Suit
  • Morrison & Foerster LLP
  • USA
  • November 23 2016

On November 2, 2016, a Florida Federal District Court issued a $29 million judgment against the marketer of Pure Green Coffee extract weight-loss


Consumer Protection in Retail: Weekly Roundup
  • Hunton & Williams LLP
  • USA
  • November 22 2016

The Eleventh Circuit Court of Appeals stayed an FTC Final Order requiring the now-defunct LabMD to implement numerous compliance measures stemming


Pharmaceutical Reps Now Required to be Licensed in the City of Chicago; Includes Code of Ethics & Potential Transparency Reporting
  • Cooley LLP
  • USA
  • November 18 2016

Earlier this week, the Chicago City Council joined other government agencies in imposing licensure and marketing requirements on pharmaceutical


Pharmaceutical Companies Face Fax Marketing TCPA Class Action
  • Klein Moynihan Turco LLP
  • USA
  • November 18 2016

On November 11, 2016, a putative class action complaint was filed against two related pharmaceutical companies alleging violations of the Telephone


FTC Issues Enforcement Policy Statement on Marketing Claims for Over-the-Counter Homeopathic Drugs
  • Arnold & Porter LLP
  • USA
  • November 17 2016

On November 15, 2016, the Federal Trade Commission (FTC) released a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC


FTC Signals Warning to Makers of Homeopathic Products
  • Hunton & Williams LLP
  • USA
  • November 17 2016

On November 15, 2016, the Federal Trade Commission released a new policy statement announcing how the agency will examine over-the-counter (“OTC”


Recommendations: line between providing information and advertising
  • Preslmayr Attorneys at Law
  • Austria
  • November 16 2016

The Supreme Court recently ruled in a case involving a request for an ophthalmologist to cease and desist from providing recommendations for